Table 1 Basic clinical characteristics, symptoms, and prognostic analysis of SFTS-VM patients
Total (n = 79) | SFTS-CVM (n = 40) | SFTS-SVM (n = 39) | P-value | |
|---|---|---|---|---|
Gender [n (%)] | 0.73 | |||
Male | 36 (45.6%) | 19 (47.5%) | 17 (43.6%) | |
Female | 43 (54.4%) | 21 (52.5%) | 22 (56.4%) | |
Age (Mean ± SD) (yrs) | 65.8 ± 7.4 | 65.0 ± 7.6 | 66.4 ± 7.3 | 0.5 |
Underlying Diseases [n (%)] | 36 (45.6) | 17 (42.5%) | 19 (48.7%) | 0.58 |
Hypertension | 21 (26.6%) | 11 (27.5%) | 10 (25.6%) | 0.85 |
Coronary Heart Disease | 7 (8.9%) | 2 (5.0%) | 5 (12.8%) | 0.22 |
Diabetes | 8 (10.1%) | 5 (12.5%) | 3 (7.7%) | 0.48 |
Chronic Lung Disease | 8 (10.1%) | 4 (10.0%) | 4 (10.3%) | 0.97 |
Chronic Liver Disease | 4 (5.1%) | 1 (2.5%) | 3 (7.7%) | 0.29 |
Tick Exposure History [n (%)] | 42 (53.2%) | 20 (50.0%) | 22 (56.4%) | 0.56 |
Complications [n (%)] | 77 (97.5%) | 38 (95.0%) | 39 (100.0%) | 0.16 |
Hepatic Dysfunction | 58 (73.4%) | 29 (72.5%) | 29 (74.4%) | 0.85 |
Renal Dysfunction | 11 (13.9%) | 4 (10.0%) | 7 (17.9%) | 0.31 |
Pneumonia | 47 (59.5%) | 18 (45.0%) | 29 (74.4%) | 0.08 |
Pancreatitis | 54 (68.4%) | 29 (72.5%) | 25 (64.1%) | 0.42 |
Encephalitis | 11 (13.9%) | 4 (10.0%) | 7 (17.9%) | 0.31 |
DIC | 10 (12.7%) | 1 (2.5%) | 9 (23.1%) | 0.06 |
MODS | 6 (7.6%) | 1 (2.5%) | 5 (12.8%) | 0.08 |
Symptoms [n (%)] | ||||
Fever | 78 (98.7%) | 40 (100.0%) | 38 (97.4%) | 0.31 |
Chills and Rigors | 19 (24.1%) | 9 (22.5%) | 10 (25.6%) | 0.74 |
Muscle Aches | 9 (11.4%) | 3 (7.5%) | 6 (15.4%) | 0.27 |
Headache | 28 (35.4%) | 16 (40.0%) | 12 (30.8%) | 0.39 |
Fatigue | 33 (41.8%) | 17 (42.5%) | 16 (41.0%) | 0.89 |
Digestive Symptoms [n (%)] | ||||
Poor Appetite | 18 (22.8%) | 8 (20.0%) | 10 (25.6%) | 0.55 |
Nausea and Vomiting | 32 (40.5%) | 16 (40.0%) | 16 (41.0%) | 0.93 |
Abdominal Pain | 9 (11.4%) | 1 (2.5%) | 8 (20.5%) | 0.01* |
Diarrhea | 47 (59.5%) | 21 (52.5%) | 26 (66.7%) | 0.2 |
Respiratory Symptoms [n (%)] | ||||
Cough with Sputum | 15 (19.0%) | 12 (30.0%) | 3 (7.7%) | 0.01* |
Central Nervous System Symptoms [n (%)] | 25 (31.6%) | 5 (12.5%) | 20 (51.3%) | < 0.01** |
Cardiovascular Symptoms [n (%)] | ||||
Chest Tightness or Chest Pain | 14 (17.7%) | 9 (22.5%) | 5 (12.8%) | 0.26 |
Hypotension or Shock | 24 (30.4%) | 0 (0.0%) | 24 (61.5%) | < 0.01** |
Time of Diagnosis Median (P25, P75) (days) | 8 (6–10) | 8(6–9) | 9(7–10) | 0.07 |
ICU Monitoring [n (%)] | ||||
Yes | 26 (32.9%) | 5 (12.5%) | 21 (53.8%) | < 0.01** |
No | 53 (67.1%) | 35 (87.5%) | 18 (46.2%) | |
Prognosis [n (%)] | ||||
Death | 13 (16.5%) | 2 (5.0%) | 11 (28.2%) | < 0.05* |
Survival | 66 (83.5%) | 38 (95.0%) | 28 (71.8%) |